The agency seeks to utilize AI to advance research and treatment options for people facing chronic and rare diseases. The U.S. Department of Health and Human Services (HHS)…
Read MorePrescription Drugs
VA and HHS Announce Psychedelic Drug Trials for Veteran Mental Health
The two organizations will partner together to increase the focus on clinical trials for psychedelic medications to treat serious mental illness. The U.S. Department of Health and Human…
Read More
EPA Reviews Request to Classify Abortion Drug as Water Contaminent
Concerns have been raised that the presence of mifepristone in water supplies could reduce the fertility of the general population. The Environmental Protection Agency is evaluating the abortion…
Read More
President Announces Hundreds of Drug Additions to TrumpRx
More than 600 generic drugs have been added to TrumpRx, to help Americans find the best prices for their medications. President Donald Trump announced earlier this week that…
Read More
HHS Takes Action to Curb Psychiatric Overprescribing
Secretary Kennedy shared information and resources and advocated for a reduction in prescription medications for mental health. The Department for Health and Human Services (HHS) announced plans to…
Read More
FDA to Pilot Real-Time Clinical Trials Through Cloud and AI
The new system is expected to expedite research reviews without changing safety standards. U.S. Food and Drug Administration (FDA) Commissioner Marty Makary announced the agency has launched a…
Read MoreSupreme Court Stays Injunction Against Telehealth Abortion Drug Prescriptions
The Fifth Circuit had ruled in Louisiana’s favor and imposed a nationwide block. The Supreme Court temporarily lifted an injunction against abortion drugs being provided via telehealth appointments…
Read More
President Trump Orders FDA to Expedite Psychedelic Drug Reviews
Ibogaine compounds have been studied as potential therapies for treating mental health. President Donald Trump ordered the Food and Drug Administration to expedite and prioritize reviews of research…
Read MoreFDA Seeks Public Input on Expedited Review Voucher Pilot Program
The agency has scheduled a hearing and comment period on initiative for faster evaluation of priority therapies. The U.S. Food and Drug Administration (FDA) recently announced a Federal…
Read More
FDA Seeks Public Input on Standards for In-Home Opioid Disposal
Request for information invites feedback on disposal products to help reduce misuse of unused medications. The U.S. Food and Drug Administration (FDA) has issued a Request for Information…
Read More